Please wait while the search results are loading...

From Korea to India to Singapore to China, Nations Compete Fiercely in Biotech Development, Business and Industry Trends Analysis

Drug companies and government research agencies in many other countries are enhancing their positions on the biotech playing field, building their own educational and technological infrastructures, and in some case creating vast new biotech research districts or complexes.  Not surprisingly, countries such as India, Singapore and China, which have already made deep inroads into other technology-based industries, are investing in major efforts in biotechnology, which is very much an information-based science.  Firms that manufacture generics and provide contract research, development and clinical trials services are already common in such nations.  In most cases, this was just a beginning, with original drug and technology development a rapidly evolving, symbiotic industry.
The government of Singapore, for example, has made biotechnology one of its top priorities for development, vowing to make it one of the staples of its economy.  Its “Biopolis” research and development center opened in 2003.  Biopolis is part of a master planned science and technology park called One-North.  The complex is recognized as a center for stem cell and cell therapy research.  It is a melting pot of scientists and corporations from all over the world, attracted to Singapore’s central location, direct airline access to all of the world’s major cities and status as a highly respected health care center with a well-educated, largely English-speaking population.  For example, the Novartis Institute for Tropical Diseases at Singapore has more than 100 researchers from 18 different nations.  Biopolis was built in five phases at an estimated cost of $700 million.  Phase I encompasses 1.99 million square feet and opened in 2003.  Phase II added two seven-story buildings (398,268 square feet total) and opened in 2006.  Phase III, completed in 2011, includes more than 400,000 square feet of laboratories, research facilities, office and retail space.  Phases IV and V, adding additional space for research and clinical trials, were completed in 2013.  (Another unit of the One-North development is called Fusionopolis, a 24-story building housing researchers, designers and entrepreneurs in media, software, communications and entertainment.)


A Representative List of Organizations that Have Used our Research and Products:



Testimonials

I’m amazed at how much information is available and the various ways to access it. This will be a major resource for our serious job seekers.

Career Services, Penn State University

Plunkett Research Online provides a great ‘one stop shop’ for us to quickly come up to speed on major industries. It provides us with an overall analysis of the market, key statistics, and overviews of the major players in the industry in an online service that is fast, easy to navigate, and reliable.

Wendy Stotts, Manager, Carlson Companies

I really appreciate the depth you were able to get to so quickly (for our project). The team has looked through the material and are very happy with the data you pulled together.

Hilton Worldwide, Marketing Manager
Real Time Web Analytics preload imagepreload image